Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment

Study ID
NCT02077868

Study type
Interventional

Study phase
Phase 3

Study status
Unknown status

Trial Acronym

IMPALA

Trial Summary

The purpose of this this trial is to prove the efficacy and safety of MGN1703 as a maintenance therapy after first-line chemotherapeutic treatment of metastatic colorectal cancer.

More informations

Trial Starting Date

Sep 30,2014

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

540